8th October 2026
If you have tried to book a private flu vaccination in the UK this autumn, you may have discovered something rather surprising.
The vaccine is not necessarily available when you want it.
Some pharmacies and private vaccination providers are finding it difficult to obtain supplies, while people who are prepared to pay privately can be told they will have to wait.
It is tempting to assume that Britain is simply running short of flu vaccine.
But that is not quite what is happening.
The NHS programme has been given separate supplies and the Government says there should be enough vaccine for everyone who is eligible and wants one.
The difficulty is more complicated, involving changes to this year's vaccine, manufacturing pressures and the availability of particular products.
All three flu strains had to be changed
Flu vaccines have to be updated every year because the viruses circulating in the population change.
This year is unusual.
All three influenza viruses included in the vaccine needed to be updated from last year's vaccine.
The UK Health Security Agency says this is one of the reasons this year's flu vaccine is being manufactured and distributed on a "just in time" basis.
The updated vaccines have to be produced in very large quantities and delivered in time for the winter season.
That leaves relatively little room for delays. UKHSA says several European countries, including England, are experiencing supply delays or more limited volumes of some vaccines this year.
There is another supply problem
There has also been a change among the companies supplying the UK.
The Government's list of flu vaccines for 2026/27 states that Viatris is not supplying flu vaccines to the UK market this season.
The remaining products are supplied by companies including Sanofi, CSL Seqirus and AstraZeneca, depending on the vaccine and age group.
Losing a supplier matters because the remaining manufacturers have to meet demand at the same time as dealing with the unusually complicated update to this year's vaccines.
For a pharmacy that has customers waiting for private vaccinations, that can create a very frustrating situation.
The pharmacy can have the staff, the appointment system and the demand.
What it cannot do is manufacture another batch of vaccine.
The NHS is not simply running out
This is an important distinction.
The current situation should not be described as the NHS running out of flu vaccine.
The latest UKHSA guidance says there should be enough vaccine for everyone eligible for an NHS flu vaccination who wants one.
The vaccines are being delivered to GP practices, pharmacies and other services in batches during the autumn and winter.
That means some people may have to wait for their particular vaccine to arrive, but UKHSA says eligible people should still be able to receive vaccination in time to provide protection during the main flu season.
The NHS programme in Scotland is also under way. NHS Inform says flu vaccinations are being offered from September 2026 and will continue for eligible groups through to March 2027.
So there is an important difference between NHS availability and private availability.
The NHS has planned supplies for its vaccination programme.
Private pharmacies and other providers depend on the commercial supply chain, where availability of some products is tighter.
But why might one person get a jab while another has to wait?
There is another complication.
There is not simply one flu vaccine.
The UK market contains several products, designed for different age groups and circumstances.
The Government's current list includes a standard vaccine, a cell-based vaccine, a recombinant vaccine, a high-dose vaccine for people aged 60 and over and an adjuvanted vaccine for people aged 50 and over, as well as the children's nasal vaccine.
That means a pharmacy can have flu vaccine in its refrigerator but still not have the particular product required for a particular customer.
UKHSA specifically warns that some people may find that a vaccine is in stock for one age group while the vaccine recommended for them is temporarily unavailable.
That is why somebody asking, "Have you got flu vaccine?" may not get a simple yes or no.
Why doesn't the NHS problem show up in the private market?
The NHS and private vaccination markets do not operate in exactly the same way.
The NHS has a national vaccination programme, with vaccine procurement and distribution planned around eligible groups.
Private pharmacies have to obtain their commercial stock through suppliers and wholesalers.
So a person who decides to pay privately rather than use the NHS may find that their local pharmacy has no vaccine available even though the NHS vaccination programme in the same area is continuing.
That can seem strange to customers.
After all, they are asking for the same basic injection.
But behind the counter there can be different purchasing arrangements and different products.
This is not a case of Britain having no flu vaccine
That distinction is worth repeating.
The official position is that there should be enough vaccine for everyone eligible for NHS vaccination.
The problem is that supplies are arriving in batches and some particular vaccines are more limited than others.
The Government has even issued guidance to healthcare professionals on prioritising certain adult vaccines because of supply and availability problems.
So somebody who cannot find a private appointment in early October should not automatically conclude that Britain has run out.
More supplies are expected.
And the NHS programme continues well beyond the beginning of October.
Why does flu vaccine have to be made so far in advance?
This is where the wider supply-chain problem becomes interesting.
Flu vaccine cannot simply be produced whenever demand increases.
Scientists have to identify the strains expected to circulate, manufacturers have to reformulate their vaccines and then produce millions of doses.
This year's situation is particularly challenging because all three vaccine strains needed updating.
The manufacturing process therefore has to be completed within a relatively narrow window.
UKHSA describes this year's supply as being produced and distributed on a "just in time" basis.
That may be efficient when everything goes according to plan.
But it leaves less room for error.
And this is where private customers feel the pain
The NHS has a planned programme and a large procurement system behind it.
The private market is different.
Someone who wants to pay £20, £30 or more for a vaccination may reasonably think:
"If I am willing to pay, surely somebody can sell me the vaccine."
But money cannot create a vaccine that is temporarily unavailable from the supplier.
The pharmacy may have demand but no stock.
That is particularly frustrating when the customer knows that vaccination appointments are being offered elsewhere through the NHS.
What does it mean for Caithness?
The issue could be more noticeable in places such as Caithness, Wick and Thurso, where there are fewer pharmacies and vaccination providers than in larger Scottish cities.
If one private provider cannot obtain stock, there may be fewer alternatives within easy travelling distance.
For someone living in a rural area, a supply problem that might be a minor inconvenience in Glasgow or Edinburgh can become a significant journey.
That is one of the less obvious consequences of relying on highly centralised pharmaceutical supply chains.
What should people do?
If you are trying to arrange a private flu vaccination, it makes sense to phone before travelling.
Ask whether the pharmacy actually has the appropriate vaccine in stock rather than simply asking whether it provides private flu vaccinations.
If it has no stock, ask when its next delivery is expected.
If you are eligible for a free NHS vaccination, there may be little advantage in paying privately if the NHS programme can provide the vaccine.
UKHSA says eligible people can use their GP practice or a pharmacy offering NHS flu vaccinations, and if one location cannot vaccinate immediately it should be able to advise when it expects to have stock.
It is a warning about "just in time"
There is a wider lesson here.
Modern pharmaceutical supply chains are designed to be efficient.
Manufacturers do not necessarily keep enormous stocks of every possible vaccine sitting in warehouses for months.
Instead, production is carefully timed around the expected winter demand.
That keeps waste and storage costs down.
But it can also make the system more sensitive to disruption.
This year, several things have happened at once.
The three flu vaccine strains needed updating.
Some vaccine supplies are arriving later or in smaller quantities.
And one established supplier, Viatris, is not supplying the UK market for the 2026/27 season.
None of this means Britain has run out of flu vaccine.
But it does show how quickly a seemingly well-organised supply chain can become stretched.
The important difference between NHS and private vaccination
For the public, the message is relatively reassuring.
The NHS says there should be enough vaccine for eligible people who want one.
The fact that somebody cannot find a private flu jab immediately does not mean the NHS programme is running out.
But for pharmacies selling vaccinations privately, the situation is rather different.
They are exposed to the availability of commercial stock and to the particular vaccine products their suppliers can provide.
That is why a person prepared to pay privately can sometimes find themselves waiting while the NHS programme continues.
A seasonal vaccine shouldn't become a last-minute scramble
We know every year that winter flu is coming.
We know that millions of people will need vaccination.
We know the vaccines have to be updated.
And we know production has to take place months before the winter season.
Yet this year the combination of three vaccine strains needing updating, manufacturing pressures and the loss of one supplier has created noticeable availability problems.
The good news is that this is not a story about the NHS running out of flu vaccine.
It is a story about how a highly organised national vaccination programme can still sit alongside a tighter private market.
For someone standing at a pharmacy counter wanting a private flu jab, however, the distinction may feel academic.
They simply want to know:
"Can you give me the injection today?"
And this autumn, in some parts of Britain, the answer is:
"Not yet."
NHS supplies are stable so go along to normal appointments for your FREE jabs.